Randomized Controlled Trial
Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
JAMA. 2006 Jul 5; 296 (1): 566356-63.
Randomized Controlled Trial
Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in...
Clin Ther. 2007 Jun 1;29(6):1040-56.
Randomized Controlled Trial
Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.
JAMA. 2006 Jul 5; 296 (1): 647164-71.